CAS: 566939-85-3 - Orteronel
Fórmula:C18H17N3O2
InChI:InChI=1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22)/t18-/m0/s1
Clave InChI:InChIKey=OZPFIJIOIVJZMN-SFHVURJKSA-N
SMILES:O=C(NC)C1=CC=C2C=C(C=CC2=C1)C3(O)C4=CN=CN4CC3
- Sinónimos:
- 6-[(7S)-6,7-Dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide
- 6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide
- TAK 700
- 2-Naphthalenecarboxamide, 6-[(7S)-6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-
- Orteronel
6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide
CAS:566939-85-3
Fórmula:
C18H17N3O2
Pureza:
99.70%
Forma y color:
Solid
Peso molecular:
307.3465
Ref: IN-DA00ECEF
5mg | 314,00 € | ||
10mg | 489,00 € | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 2 de Diciembre de 2024
CYP17A1 Inhibitor II, TAK-700
CAS:566939-85-3
TAK-700 is a CYP17A1 inhibitor that prevents the production of androgens by inhibiting the activity …
Fórmula:
C18H17N3O2
Pureza:
Min. 95%
Peso molecular:
307.35 g/mol
Ref: 3D-RXA93985
5mg | 334,00 € | ||
10mg | 502,00 € | ||
25mg | 799,00 € | ||
50mg | 1.203,00 € | ||
100mg | 1.924,00 € |
Entrega estimada en Estados Unidos, el Viernes 13 de Diciembre de 2024
Orteronel
CAS:566939-85-3
Orteronel ((S)-Orteronel)(TAK-700) was selected as a candidate for clinical evaluation.
Fórmula:
C18H17N3O2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
307.35
Ref: TM-T6051
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 19 de Diciembre de 2024
Orteronel
Producto controladoCAS:566939-85-3
Fórmula:
C18H17N3O2
Forma y color:
Neat
Peso molecular:
307.346
Ref: TR-O697600
1g | 9.017,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025